These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31137731)

  • 21. Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens.
    Pradhan SN; Prince PR; Madhumathi J; Roy P; Narayanan RB; Antony U
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):293-301. PubMed ID: 22795186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide.
    Mahmood MS; Siddique M; Hussain I; Khan A; Mansoor MK
    Vaccine; 2006 May; 24(22):4838-46. PubMed ID: 16600440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens.
    Rong J; Jiang T; Cheng T; Shen M; Du Y; Li S; Wang S; Xu B; Fan G
    Vaccine; 2007 Nov; 25(46):7900-8. PubMed ID: 17923174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
    Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
    Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.
    Huang Z; Elankumaran S; Yunus AS; Samal SK
    J Virol; 2004 Sep; 78(18):10054-63. PubMed ID: 15331738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by the attenuated Salmonella elicits protective immune responses in chickens.
    Li L; Fang W; Li J; Huang Y; Yu L
    Vaccine; 2006 Aug; 24(33-34):5919-27. PubMed ID: 16769159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cloning of chicken IL-7 and characterization of its antiviral activity against IBDV in vivo.
    Huo S; Wang L; Zhang Y; Zhang J; Zuo Y; Xu J; Cui D; Li X; Zhong F
    Poult Sci; 2016 Nov; 95(11):2647-2654. PubMed ID: 27466431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses.
    Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J
    Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant Lactococcus Expressing a Novel Variant of Infectious Bursal Disease Virus VP2 Protein Can Induce Unique Specific Neutralizing Antibodies in Chickens and Provide Complete Protection.
    Wang Z; Mi J; Wang Y; Wang T; Qi X; Li K; Pan Q; Gao Y; Gao L; Liu C; Zhang Y; Wang X; Cui H
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33255742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-mediated vaccination conferring protection against infectious bursal disease in broiler chickens in the presence of maternal antibody.
    Hsieh MK; Wu CC; Lin TL
    Vaccine; 2010 May; 28(23):3936-43. PubMed ID: 20394722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity.
    Heine HG; Hyatt AD; Boyle DB
    Virus Res; 1994 Jun; 32(3):313-28. PubMed ID: 8079513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembly of the infectious bursal disease virus capsid protein, rVP2, expressed in insect cells and purification of immunogenic chimeric rVP2H particles by immobilized metal-ion affinity chromatography.
    Wang MY; Kuo YY; Lee MS; Doong SR; Ho JY; Lee LH
    Biotechnol Bioeng; 2000 Jan; 67(1):104-11. PubMed ID: 10581441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
    Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease.
    Hsieh MK; Wu CC; Lin TL
    Vaccine; 2007 Jul; 25(29):5417-27. PubMed ID: 17561315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.